Who Paid My Doc
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Dose Find
Research payments
$3,148,779
Through program year 2025, $3,148,779 in research payments was reported against A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Dose Find, across 352 payments, paid by GlaxoSmithKline, LLC..
- Paid by
- GlaxoSmithKline, LLC.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $3,148,779 | 352 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Barbara Baxter Dallas, TX Named on 26 payments
- Jonathan Bernstein Cincinnati, OH Named on 23 payments
- Ileana Rodicio Miami, FL Named on 18 payments
- Jaime Landman Fort Lauderdale, FL Named on 17 payments
- Sumbul Islam Sherman, TX Named on 17 payments
- Syed Raza Southfield, MI Named on 14 payments
- David Fuentes Boerne, TX Named on 14 payments
- Jose Diaz The Villages, FL Named on 11 payments
- Alberto Manzor Pembroke Pines, FL Named on 11 payments
- Michael Palumbo Washington, PA Named on 10 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.